miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer
出版年份 2014 全文链接
标题
miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer
作者
关键词
-
出版物
ONCOGENE
Volume 34, Issue 6, Pages 717-725
出版商
Springer Nature
发表日期
2014-03-10
DOI
10.1038/onc.2014.9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Integrated Analyses Identify a Master MicroRNA Regulatory Network for the Mesenchymal Subtype in Serous Ovarian Cancer
- (2013) Da Yang et al. CANCER CELL
- Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state
- (2013) Y.-Y. Lim et al. JOURNAL OF CELL SCIENCE
- Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1
- (2013) P Wang et al. ONCOGENE
- Hedgehog Gli3 activator signal augments tumorigenicity of colorectal cancer via upregulation of adherence-related genes
- (2012) Hironori Iwasaki et al. CANCER SCIENCE
- Up-regulation of microRNA 506 leads to decreased Cl−/HCO3− anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis
- (2012) Jesús M. Banales et al. HEPATOLOGY
- MicroRNAs Reprogram Normal Fibroblasts into Cancer-Associated Fibroblasts in Ovarian Cancer
- (2012) A. K. Mitra et al. Cancer Discovery
- Targeting miR-506 in primary biliary cirrhosis to support the HCO3− umbrella
- (2012) Rui E. Castro et al. Clinics and Research in Hepatology and Gastroenterology
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Abrogation of Gli3 expression suppresses the growth of colon cancer cells via activation of p53
- (2011) Han Na Kang et al. EXPERIMENTAL CELL RESEARCH
- MicroRNA 506 regulates expression of PPAR alpha in hydroxycamptothecin-resistant human colon cancer cells
- (2011) Jin Lu Tong et al. FEBS LETTERS
- A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth
- (2011) K L Streicher et al. ONCOGENE
- The role of miR-506 in transformed 16HBE cells induced by anti-benzo[a]pyrene-trans-7,8-dihydrodiol-9,10-epoxide
- (2011) Yao Zhao et al. TOXICOLOGY LETTERS
- Gli3 mediates cell survival and sensitivity to cyclopamine in pancreatic cancer
- (2010) Adam Steg et al. CANCER BIOLOGY & THERAPY
- Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer
- (2010) Saskia M Wilting et al. Molecular Cancer
- miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma
- (2009) Mayuko Furuta et al. CARCINOGENESIS
- The Hedgehog Transcription Factor Gli3 Modulates Angiogenesis
- (2009) Marie-Ange Renault et al. CIRCULATION RESEARCH
- miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1
- (2009) Kay Ka Wai Li et al. HUMAN PATHOLOGY
- Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors
- (2009) Robert H Kutner et al. Nature Protocols
- Expression of Sonic hedgehog signaling molecules in normal, hyperplastic and carcinomatous endometrium
- (2009) Kyung Hee Kim et al. PATHOLOGY INTERNATIONAL
- miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells
- (2008) Joachim Silber et al. BMC Medicine
- Reducing Uncertainties About the Effects of Chemoradiotherapy for Cervical Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 18 Randomized Trials
- (2008) JOURNAL OF CLINICAL ONCOLOGY
- Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma
- (2008) Jessica Pierson et al. JOURNAL OF NEURO-ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started